Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Disease Factors and Not Comorbidity Drives Clinical Decisions in Elderly Patients with Follicular Lymphoma

Prathima Reddy, MD, Ajay K. Gopal, MD, Brian G. Till, MD, Mazyar Shadman, MD, Edus H. Warren, III, MDPhD, Andrei Shustov, MD, Ryan D. Cassaday, MD, Oliver W. Press, MD PhD, Stephen D. Smith, MD

Blood (2017) 130 (Supplement 1): 2119.

https://doi.org/10.1182/blood.V130.Suppl_1.2119.2119

Published: 2017

Journal Articles

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Blood (2017) 130 (Supplement 1): 1699.

https://doi.org/10.1182/blood.V130.Suppl_1.1699.1699

Published: 2017

Journal Articles

Simultaneous Detection of Single Nucleotide Variants and Expression of RNA and Protein in Multiple Myeloma Bone Marrow Aspirates

David G. Coffey, MD, Katherine A. Lombardo, BS, Andrea M.H. Towlerton, BS, MaryCatherine A. Farwell, BS, Gokhan Demirkan, PhD, Gavin Meredith, PhD, Rhonda Meredith, BSc, Damian J. Green, MD, Edus H. Warren, III, MDPhD

Blood (2017) 130 (Supplement 1): 1758.

https://doi.org/10.1182/blood.V130.Suppl_1.1758.1758

Published: 2017

Journal Articles

Targeted Next Generation Sequencing of Circulating Tumor DNA in Multiple Myeloma

David G. Coffey, MD, Sharon Ornelas, BS, Andrea M.H. Towlerton, BS, Edus H. Warren, III, MDPhD

Blood (2017) 130 (Supplement 1): 4337.

https://doi.org/10.1182/blood.V130.Suppl_1.4337.4337

Published: 2017

Journal Articles

Comparative Analysis of Endemic and Sporadic Burkitt Lymphoma By RNA Sequencing

David G. Coffey, MD, Katharine A. Lombardo, BS, Andrea M. H. Towlerton, BS, Sarah E. Gerdts, MPH, Corey Casper, MD, Jackson Orem, MD, Edus H. Warren, III, MD PhD

Blood (2015) 126 (23): 3896.

https://doi.org/10.1182/blood.V126.23.3896.3896

Published: 2015

Journal Articles

Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans

Hideki Nakasone, Lu Tian, Bita Sahaf, Takakazu Kawase, Kelsi Schoenrock, Spenser Perloff, Christine E. Ryan, Jed Paul, Rakesh Popli, Fang Wu, Joanne M. Otani, John Coller, Edus H. Warren, III, David B. Miklos

Blood (2015) 125 (20): 3193–3201.

https://doi.org/10.1182/blood-2014-11-613323

Published: 2015

Includes: Supplemental data

Journal Articles

Preclinical Evaluation Of Engineered T Cells In Multiple Myeloma: Uncovering a Mechanism Of Immune Escape

Zandra K. Klippel, MD, Jeffrey Chou, MD, PhD, Andrea M. H. Towlerton, Paul F Robbins, PhD, Lilien Voong, William I. Bensinger, MD, H. Lokhorst, Tuna Mutis, MD, PhD, Lihua Elizabeth Budde, MD, PhD, Edus H. Warren, III, MD, PhD

Blood (2013) 122 (21): 4205.

https://doi.org/10.1182/blood.V122.21.4205.4205

Published: 2013

Journal Articles

Allogeneic HY Antibodies 3 Months Following Sex-Mismatched HCT Predicts Chronic Graft-Versus-Host Disease and Non-Relapse Mortality

Hideki Nakasone, MD, PhD, Lu Tian, Takakazu Kawase, M.D., Bita Sahaf, PhD, Rakesh Popli, Joyce Lee, Kelsi Schoenrock, Spenser Perloff, Fang Wu, Joanne M Otani, RN, MSN, Andrea M. H. Towlerton, Shoko Satoh, Edus H. Warren, III, MD, PhD, David B. Miklos, MD, PhD

Blood (2013) 122 (21): 147.

https://doi.org/10.1182/blood.V122.21.147.147

Published: 2013

Journal Articles

Epigenetic Regulation of Cancer-Testis Antigen Expression in Multiple Myeloma and Correlation with High-Risk Cytogenetics.

Zandra K. Klippel, MD, Akshay Srivatsan, Andrea M. H. Towlerton, Jeffrey Chou, MD, PhD, Tuna Mutis, MD PhD, Henk Lokhorst, William I. Bensinger, MD, Edus H. Warren, III, MD, PhD

Blood (2012) 120 (21): 2923.

https://doi.org/10.1182/blood.V120.21.2923.2923

Published: 2012

Journal Articles

T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection

Colleen Delaney, MD, MSc, Ryan O Emerson, PhD, Filippo Milano, MD, PhD, Anna Sherwood, PhD, Adrienne Papermaster, Katherine A. Guthrie, PhD, Christopher S Carlson, PhD, Edus H. Warren, III, MD, PhD, Harlan Robins, PhD

Blood (2012) 120 (21): 4202.

https://doi.org/10.1182/blood.V120.21.4202.4202

Published: 2012

Journal Articles

Frequency and Intensity of Antibody Responses to Antigens Encoded by KDM5D (SMCY) and Other H-Y Genes After Allogeneic Hematopoietic Cell Transplantation,

Takakazu Kawase, MD, PhD, Nathan D. Ord, Andrea Towlerton, Shoko Satoh, Tara Bumgarner, Mary E.D. Flowers, MD, Stephanie J. Lee, MD, MPH, Paul J Martin, MD, Stanley R. Riddell, MD, John A. Hansen, MD, David B Miklos, MD, PhD, Edus H. Warren, III, MD, PhD

Blood (2011) 118 (21): 4028.

https://doi.org/10.1182/blood.V118.21.4028.4028

Published: 2011

Journal Articles

Association of Graft-Versus-Host Disease and Immunosuppressive Treatment with Risks of Recurrent Malignancy and Mortality After Allogeneic Hematopoietic Cell Transplantation

Yoshihiro Inamoto, Mary E.D. Flowers, Stephanie J. Lee, Paul A. Carpenter, Edus H. Warren, III, H. Joachim Deeg, Rainer F. Storb, Frederick R. Appelbaum, Barry E. Storer, Paul J. Martin

Blood (2010) 116 (21): 218.

https://doi.org/10.1182/blood.V116.21.218.218

Published: 2010

Journal Articles

HLA and TCR Knockout by Zinc Finger Nucleases: Toward “off-the-Shelf” Allogeneic T-Cell Therapy for CD19 + Malignancies.

Hiroki Torikai, Andreas Reik, Carrie Yuen, Yuanyue Zhou, Denise Kellar, Helen Huls, Edus H. Warren, III, Scott S. Tykodi, Philip D. Gregory, Michael C. Holmes, Edward J. Rebar, Dean A. Lee, Richard E. Champlin, Chiara Bonini, Laurence Cooper

Blood (2010) 116 (21): 3766.

https://doi.org/10.1182/blood.V116.21.3766.3766

Published: 2010

Journal Articles

Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.

Jennifer Vaughn, MD, MSPH, Barry Storer, PhD, Marco Mielcarek, MD, Edus H. Warren, III, MD, PhD, Paul J. Martin, MD, Brenda M. Sandmaier, MD, Elihu H. Estey, MD, Rainer Storb, MD, H. Joachim Deeg, MD, Bart Lee Scott, MD

Blood (2010) 116 (21): 1288.

https://doi.org/10.1182/blood.V116.21.1288.1288

Published: 2010

Journal Articles

Identification of Novel MHC Class II-Restricted Male-Specific mHAg Encoded by SMCY ( JARID1D ). .

Nobuharu Fujii, MD, PhD, Kellie V Rosinski, Paulo V Campregher, MD, Edus H Warren, III, MD, PhD

Blood (2009) 114 (22): 1344.

https://doi.org/10.1182/blood.V114.22.1344.1344

Published: 2009

Journal Articles

Generation of CD8 + Cytotoxic T Cell Clones Recognizing BMI1-Derived Peptides

Nobuharu Fujii, MD, PhD, Cameron J Turtle, MBBS, PhD, Paulo V Campregher, MD, Edus H Warren, III, MD, PhD

Blood (2008) 112 (11): 2909.

https://doi.org/10.1182/blood.V112.11.2909.2909

Published: 2008

NARROW

Disease Factors and Not Comorbidity Drives Clinical Decisions in Elderly Patients with Follicular Lymphoma

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Simultaneous Detection of Single Nucleotide Variants and Expression of RNA and Protein in Multiple Myeloma Bone Marrow Aspirates

Targeted Next Generation Sequencing of Circulating Tumor DNA in Multiple Myeloma

Comparative Analysis of Endemic and Sporadic Burkitt Lymphoma By RNA Sequencing

Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans

Preclinical Evaluation Of Engineered T Cells In Multiple Myeloma: Uncovering a Mechanism Of Immune Escape

Allogeneic HY Antibodies 3 Months Following Sex-Mismatched HCT Predicts Chronic Graft-Versus-Host Disease and Non-Relapse Mortality

Epigenetic Regulation of Cancer-Testis Antigen Expression in Multiple Myeloma and Correlation with High-Risk Cytogenetics.

T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection

Frequency and Intensity of Antibody Responses to Antigens Encoded by KDM5D (SMCY) and Other H-Y Genes After Allogeneic Hematopoietic Cell Transplantation,

Association of Graft-Versus-Host Disease and Immunosuppressive Treatment with Risks of Recurrent Malignancy and Mortality After Allogeneic Hematopoietic Cell Transplantation

HLA and TCR Knockout by Zinc Finger Nucleases: Toward “off-the-Shelf” Allogeneic T-Cell Therapy for CD19 + Malignancies.

Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.

Identification of Novel MHC Class II-Restricted Male-Specific mHAg Encoded by SMCY ( JARID1D ). .

Generation of CD8 + Cytotoxic T Cell Clones Recognizing BMI1-Derived Peptides

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only